In a filing, Alzamend Neuro Inc revealed its Director AULT MILTON C III unloaded Company’s shares for reported $0.22 million on Jul 31 ’25. In the deal valued at $2.22 per share,100,000 shares were sold. As a result of this transaction, AULT MILTON C III now holds 8,260 shares worth roughly $20154.399999999998.
Then, AULT MILTON C III sold 29,449 shares, generating $73,982 in total proceeds. Upon selling the shares at $2.51, the Director now owns 108,260 shares.
Before that, AULT MILTON C III sold 36,532 shares. Alzamend Neuro Inc shares valued at $105,855 were divested by the Director at a price of $2.90 per share. As a result of the transaction, AULT MILTON C III now holds 46,020 shares, worth roughly $0.11 million.
Ascendiant Capital Markets initiated its Alzamend Neuro Inc [ALZN] rating to a Buy in a research note published on October 01, 2021; the price target was $8.
Price Performance Review of ALZN
On Friday, Alzamend Neuro Inc [NASDAQ:ALZN] saw its stock jump 0.41% to $2.44. Over the last five days, the stock has lost -2.01%. Alzamend Neuro Inc shares have fallen nearly -89.33% since the year began. Nevertheless, the stocks have fallen -76.63% over the past one year. While a 52-week high of $24.93 was reached on 01/07/25, a 52-week low of $2.06 was recorded on 08/01/25.
Levels Of Support And Resistance For ALZN Stock
The 24-hour chart illustrates a support level at 2.37, which if violated will result in even more drops to 2.29. On the upside, there is a resistance level at 2.52. A further resistance level may holdings at 2.59.
How much short interest is there in Alzamend Neuro Inc?
A steep rise in short interest was recorded in Alzamend Neuro Inc stocks on 2025-08-15, growing by 68405.0 shares to a total of 0.16 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 88987.0 shares. There was a rise of 43.46%, which implies that there is a positive sentiment for the stock.
